129 related articles for article (PubMed ID: 18660676)
1. Revisiting the glomerular charge barrier in the molecular era.
Harvey SJ; Miner JH
Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):393-8. PubMed ID: 18660676
[TBL] [Abstract][Full Text] [Related]
2. Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria.
van den Hoven MJ; Wijnhoven TJ; Li JP; Zcharia E; Dijkman HB; Wismans RG; Rops AL; Lensen JF; van den Heuvel LP; van Kuppevelt TH; Vlodavsky I; Berden JH; van der Vlag J
Kidney Int; 2008 Feb; 73(3):278-87. PubMed ID: 18046314
[TBL] [Abstract][Full Text] [Related]
3. Heparan sulfate of perlecan is involved in glomerular filtration.
Morita H; Yoshimura A; Inui K; Ideura T; Watanabe H; Wang L; Soininen R; Tryggvason K
J Am Soc Nephrol; 2005 Jun; 16(6):1703-10. PubMed ID: 15872080
[TBL] [Abstract][Full Text] [Related]
4. Glomerular filtration is normal in the absence of both agrin and perlecan-heparan sulfate from the glomerular basement membrane.
Goldberg S; Harvey SJ; Cunningham J; Tryggvason K; Miner JH
Nephrol Dial Transplant; 2009 Jul; 24(7):2044-51. PubMed ID: 19144998
[TBL] [Abstract][Full Text] [Related]
5. Recent insights into the structure and functions of heparan sulfate proteoglycans in the human glomerular basement membrane.
Groffen AJ; Veerkamp JH; Monnens LA; van den Heuvel LP
Nephrol Dial Transplant; 1999 Sep; 14(9):2119-29. PubMed ID: 10489220
[TBL] [Abstract][Full Text] [Related]
6. Disruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivity.
Harvey SJ; Jarad G; Cunningham J; Rops AL; van der Vlag J; Berden JH; Moeller MJ; Holzman LB; Burgess RW; Miner JH
Am J Pathol; 2007 Jul; 171(1):139-52. PubMed ID: 17591961
[TBL] [Abstract][Full Text] [Related]
7. The glomerular basement membrane charge-selectivity barrier: an oversimplified concept?
Goode NP; Shires M; Davison AM
Nephrol Dial Transplant; 1996 Sep; 11(9):1714-6. PubMed ID: 8918607
[No Abstract] [Full Text] [Related]
8. The role of heparanase and the endothelial glycocalyx in the development of proteinuria.
Garsen M; Rops AL; Rabelink TJ; Berden JH; van der Vlag J
Nephrol Dial Transplant; 2014 Jan; 29(1):49-55. PubMed ID: 24166469
[TBL] [Abstract][Full Text] [Related]
9. Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation.
Borza DB
Matrix Biol; 2017 Jan; 57-58():299-310. PubMed ID: 27609404
[TBL] [Abstract][Full Text] [Related]
10. Glomerular permeability is not affected by heparan sulfate glycosaminoglycan deficiency in zebrafish embryos.
Khalil R; Lalai RA; Wiweger MI; Avramut CM; Koster AJ; Spaink HP; Bruijn JA; Hogendoorn PCW; Baelde HJ
Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1211-F1216. PubMed ID: 31461353
[TBL] [Abstract][Full Text] [Related]
11. Heparanase in glomerular diseases.
van den Hoven MJ; Rops AL; Vlodavsky I; Levidiotis V; Berden JH; van der Vlag J
Kidney Int; 2007 Sep; 72(5):543-8. PubMed ID: 17519955
[TBL] [Abstract][Full Text] [Related]
12. Pathobiochemical aspects of diabetic nephropathy.
Schleicher E; Nerlich A; Gerbitz KD
Klin Wochenschr; 1988 Sep; 66(18):873-82. PubMed ID: 2972877
[TBL] [Abstract][Full Text] [Related]
13. Heparanase in Kidney Disease.
van der Vlag J; Buijsers B
Adv Exp Med Biol; 2020; 1221():647-667. PubMed ID: 32274730
[TBL] [Abstract][Full Text] [Related]
14. Heparan sulfate proteoglycans in glomerular inflammation.
Rops AL; van der Vlag J; Lensen JF; Wijnhoven TJ; van den Heuvel LP; van Kuppevelt TH; Berden JH
Kidney Int; 2004 Mar; 65(3):768-85. PubMed ID: 14871397
[TBL] [Abstract][Full Text] [Related]
15. A specific structural alteration in the heparan sulphate of human glomerular basement membrane in diabetes.
Edge AS; Spiro RG
Diabetologia; 2000 Aug; 43(8):1056-9. PubMed ID: 10990084
[TBL] [Abstract][Full Text] [Related]
16. Changes in heparan sulfate correlate with increased glomerular permeability.
Groggel GC; Stevenson J; Hovingh P; Linker A; Border WA
Kidney Int; 1988 Feb; 33(2):517-23. PubMed ID: 2452273
[TBL] [Abstract][Full Text] [Related]
17. Regulation of basement membrane heparan sulfate proteoglycan, perlecan, gene expression in glomerular epithelial cells by high glucose medium.
Kasinath BS; Grellier P; Choudhury GG; Abboud SL
J Cell Physiol; 1996 Apr; 167(1):131-6. PubMed ID: 8698830
[TBL] [Abstract][Full Text] [Related]
18. The role of heparanase in diseases of the glomeruli.
Szymczak M; Kuźniar J; Klinger M
Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):45-56. PubMed ID: 20049646
[TBL] [Abstract][Full Text] [Related]
19. Loss of heparan sulfate proteoglycan from glomerular basement membrane of nephrotic rats.
Mynderse LA; Hassell JR; Kleinman HK; Martin GR; Martinez-Hernandez A
Lab Invest; 1983 Mar; 48(3):292-302. PubMed ID: 6219248
[TBL] [Abstract][Full Text] [Related]
20. The charge for going by foot: modifying the surface of podocytes.
Pavenstädt H
Exp Nephrol; 1998; 6(2):98-103. PubMed ID: 9567215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
